News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
361–396
Matches
509
Sources here
25
Companies here
12
Search results Stored financial headlines

Active search

509 matching headlines

Ticker or company: DOCMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Is Teladoc Health (TDOC) Undervalued As Teladoc One Tests The AI Health Threat?

Teladoc Health (TDOC) is gaining attention after launching Teladoc One, an AI-supported virtual care platform, amidst discussions around the impact of AI in healthcare. Despite a strong recent share price rebound of 52.52% over 90 days and 24.40% year-to-date, its five-year return is down …

TDOC main company
Sharemaestro market context Trend signal active 52 weeks -11.3% TDOC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

DCGO|DocGo Inc|Price:0.708|Chg%:+0.040

This article provides a comprehensive stock analysis of DocGo Inc (DCGO), highlighting its relatively healthy fundamentals, high growth potential, and "fairly valued" status. It notes high institutional ownership and recent analyst ratings of "Buy" with a target price suggesting significant upside. The analysis also …

DCGO main company
Sharemaestro market context Price above Trend Line 52 weeks -61.2% DCGO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BofA Securities Maintains Teladoc Health(TDOC.US) With Buy Rating, Maintains Target Price $10.5

BofA Securities has reiterated its Buy rating on Teladoc Health (TDOC.US) and maintained its price target of $10.5. This indicates a continued positive outlook from the firm regarding Teladoc's stock performance.

TDOC main company
Sharemaestro market context Trend signal active 52 weeks -11.3% TDOC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PRDO|Perdoceo Education Corp|Price:30.820|Chg%:+1.410

Perdoceo Education Corp (PRDO) shows strong fundamentals with high growth potential, fair valuation, and very high institutional ownership. Analysts have rated it a Strong Buy with a target price of $44.00, indicating a 44.22% upside. Despite recent market weakness, the stock is expected to …

PRDO main company
Sharemaestro market context Price below Trend Line 52 weeks -2.2% · Next-week setup positive 58.4% PRDO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Form 144 AMDOCS LTD For: 23 July By Investing.com

This article briefly reports on the filing of Form 144 for Amdocs Ltd (DOX) on July 23, 2026. Form 144 is filed with the SEC to announce the intent to sell restricted or control securities. The article provides the company's stock symbol and a …

DOX main company
Sharemaestro market context New activity signal 52 weeks -32.6% DOX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

DocuSign (DOCU) Registers a Bigger Fall Than the Market: Important Facts to Note

DocuSign (DOCU) shares fell by 1.77% in the latest trading session, underperforming the broader market despite gaining 8.25% over the past month. The company is set to release its financial results, with analysts forecasting significant EPS and revenue growth year-over-year. Investors are watching for …

DOCU main company D1OC34 main company DOCU main company
Sharemaestro market context Trend signal started 52 weeks -26.5% DOCU stored weekly price path from 22 Aug 2025 to 14 Aug 2026

DOCU: DocuSign Inc Latest Stock Price, Analysis, News and Trading Ideas

This article provides the latest stock information for DocuSign Inc (DOCU), including its current price, market capitalization, P/E ratio, and recent news. It also highlights analyst opinions from Zacks, noting that DocuSign is considered both a strong growth and value stock, despite a recent …

DOCU main company
Sharemaestro market context Trend signal active 52 weeks -17.1% DOCU stored weekly price path from 22 Aug 2025 to 14 Aug 2026

DocuSign stock trades steady as subscription growth and cash flow support valuation

DocuSign’s stock is being driven by a combination of moderating revenue growth and improving profitability. The company's fiscal 2024 results revealed total revenue of approximately $2.8 billion, with subscription revenue exceeding $2.7 billion, and significant improvements in operating margin and free cash flow. This …

DOCU main company
Sharemaestro market context Trend signal active 52 weeks -17.1% DOCU stored weekly price path from 22 Aug 2025 to 14 Aug 2026

TDOC, AMWL Stocks Retreat After OpenAI Lets Users Link Medical Records To ChatGPT

Shares of telehealth platforms Teladoc Health (TDOC) and American Well Corp (AMWL) fell after OpenAI launched an expanded Health experience in ChatGPT, allowing users to link personal health data for personalized responses. This new feature overlaps with services offered by telehealth companies, potentially causing …

TDOC main company
Sharemaestro market context Trend signal active 52 weeks -11.3% TDOC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Teladoc, GoodRx shares fall on OpenAI health feature launch

Shares of Teladoc Inc (NYSE:TDOC) and GoodRx Holdings Inc (NASDAQ:GDRX) fell after OpenAI unveiled a new health feature in ChatGPT. This feature allows U.S. users to connect medical records and Apple Health data to the AI chatbot, enabling tasks like comparing lab results and …

TDOC main company
Sharemaestro market context Trend signal active 52 weeks -11.3% TDOC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Teladoc (TDOC) Shares Decline in Afternoon Trading

Teladoc Health Inc. (TDOC) saw its shares drop by 3% in afternoon trading on July 23, 2026, closing at $8.64. This decline is attributed to ongoing challenges in the telehealth sector, reflected in the company's moderate GF Score™ of 61 and insider selling activities …

TDOC main company T2DH34 main company TDOC main company
Sharemaestro market context Trend signal active 52 weeks -17.6% TDOC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Amdocs (DOX) affiliate plans Rule 144 sale of 107,577 ordinary shares

An affiliate of Amdocs Limited (DOX) has filed a Rule 144 notice to sell 107,577 ordinary shares, with an aggregate market value of $5,510,093.94, through Oppenheimer & Co. Inc. on Nasdaq. These shares originated from restricted stock units (RSUs) that vested between November 2020 …

DOX main company
Sharemaestro market context New activity signal 52 weeks -32.6% DOX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Teladoc launches personalized, risk-based virtual care model

Teladoc Health has introduced Teladoc One, a new personalized, risk-based virtual care model leveraging an AI-driven engine to unify services, care teams, and data. This model aims to deliver individualized care by linking payments to medical cost savings and clinical outcomes, initially focusing on …

TDOC main company
Sharemaestro market context Trend signal active 52 weeks -11.3% TDOC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Teladoc (TDOC) Stock May Be 41% Undervalued On Cash Flow Strength

Teladoc Health (TDOC) stock appears significantly undervalued, trading at an estimated 41.3% discount based on a Discounted Cash Flow (DCF) analysis, which projects future cash flows. Despite a 94.1% decline over the past five years, its current price of around US$8.92 is considered cheap …

TDOC main company
Sharemaestro market context Trend signal active 52 weeks -11.3% TDOC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Teladoc Health introduces a virtual care practice built around the person, shaping a new era of connected care

Teladoc Health has announced Teladoc One, a new virtual care model designed to address fragmented healthcare by providing personalized, adaptive, and connected care. This model, launching with select clients in September 2026, leverages AI and multidisciplinary teams to coordinate care across various settings and …

TDOC main company
Sharemaestro market context Trend signal active 52 weeks -11.3% TDOC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Teladoc Health Introduces Teladoc One To Deliver Connected And Adaptive Virtual Care

Teladoc Health has launched Teladoc One, a new virtual care model designed to provide a connected, predictive, and adaptive healthcare experience tailored to individuals. This model aims to address fragmented care by integrating various health data points through its Pulse intelligence engine and coordinating …

TDOC main company
Sharemaestro market context Trend signal active 52 weeks -11.3% TDOC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Teladoc Health launches new virtual care model with fees at risk

Teladoc Health has introduced "Teladoc One," a new virtual care model that integrates various health services into a single platform. This model employs multidisciplinary care teams and AI-driven intelligence to coordinate care. Significantly, Teladoc Health is placing 100% of its fees at risk, linking …

TDOC main company
Sharemaestro market context Trend signal active 52 weeks -11.3% TDOC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Docebo Inc. (DCBO) stock price, news, quote and history

This page provides a comprehensive overview of Docebo Inc. (DCBO) stock, including its current price, historical data, financial performance, and recent news. Docebo, a Canadian company, specializes in providing a cloud-based learning management platform globally. The stock closed at $19.37, up 2.00%, with a …

DCBO main company
Sharemaestro market context Trend signal active 52 weeks -26.0% · Next-week setup negative 43.5% DCBO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Amdocs (DOX) Could Be 38% Undervalued As Sales Weakness Clouds The Outlook

Recent analysis suggests that Amdocs (DOX) may be 38% undervalued despite declining annual sales and earnings growth compared to peers. The company's financials feature strong recurring revenue streams, a high renewal rate for managed services, and a substantial 12-month backlog, supporting a fair value …

DOX main company
Sharemaestro market context New activity signal 52 weeks -32.6% DOX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Teladoc Health unveils new virtual care model for employers, health plans that ties payment to results

Teladoc Health has launched Teladoc One, a new virtual care model for employers and health plans that integrates care across various health needs, moving away from fragmented, condition-specific programs. The model aims to improve clinical outcomes and reduce healthcare costs, with 100% of Teladoc's …

TDOC main company
Sharemaestro market context Trend signal active 52 weeks -11.3% TDOC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Perdoceo Education to report Q2FY26 results on August 6

Perdoceo Education Corporation will release its Q2 FY26 financial results after market close on August 6, 2026. The company will host a live conference call and webcast at 4:30 p.m. ET on the same day to discuss the results and its 2026 outlook. Interested …

PRDO main company
Sharemaestro market context Price below Trend Line 52 weeks -2.2% · Next-week setup positive 58.4% PRDO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Teladoc Health (TDOC) Q2 2024 earnings summary

Teladoc Health (TDOC) reported a Q2 2024 revenue decline of 2% year-over-year to $642.4 million, largely due to lower performance in its BetterHelp segment, resulting in a net loss of $837.7 million driven by a significant non-cash goodwill impairment charge. Despite this, adjusted EBITDA …

TDOC main company
Sharemaestro market context Trend signal active 52 weeks -11.3% TDOC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Healthpeak ends 11 cents below its high after a 38% quarter, while volume trails the move

The healthcare REIT’s weekly trend remains active and sector breadth is supportive, but the latest advance came on only 0.7x normal volume with valuation distance now stretched.

DOC main company
Sharemaestro market context Trend signal active 52 weeks +24.0% DOC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

DocuSign Drops 6.1% Amid Sector-Wide Selling

DocuSign (DOCU) experienced a 6.1% drop to $47.65 on Wednesday, part of a broad selloff impacting software stocks. This decline mirrored similar losses in sector peers like HubSpot, Palantir Technologies, Manhattan Associates, and Bentley Systems, suggesting a wider market sentiment shift away from growth-oriented …

DOCU main company
Sharemaestro market context Trend signal active 52 weeks -17.1% DOCU stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Docebo Inc. Is Maintained at Outperform by ATB Cormark

Docebo Inc. (NASDAQ:DCBO) has had its "Outperform" rating reiterated by ATB Cormark. This analyst rating suggests that ATB Cormark believes Docebo's stock is likely to perform better than the broader market or its industry.

DCBO main company
Sharemaestro market context Trend signal active 52 weeks -26.0% · Next-week setup negative 43.5% DCBO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CCORF Maintains Teladoc Health(TDOC.US) With Buy Rating, Raises Target Price to $11

CCORF has reiterated its Buy rating for Teladoc Health (TDOC.US) and increased its target price to $11. This indicates continued confidence in the company's performance and future prospects.

TDOC main company
Sharemaestro market context Trend signal active 52 weeks -11.3% TDOC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

How Investors Are Reacting To Amdocs (DOX) Slowing Sales Despite Rising Earnings And Low Valuation

Amdocs (DOX) is facing investor caution due to a 3.6% sales decline over the past two years and a forecast of only 3.2% growth, despite an 8.1% annual increase in EPS and a low forward P/E of 6.8x. This hesitancy stems from concerns that …

DOX main company
Sharemaestro market context New activity signal 52 weeks -32.6% DOX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Docebo Inc. Announces Commencement Of Previously Announced Substantial Issuer Bid

Docebo Inc. has announced the commencement of its previously declared substantial issuer bid. The full details of this announcement are available via a 30-day free trial on the Refinitiv platform. This news was published by Reuters through TradingView.

DCBO main company
Sharemaestro market context Trend signal active 52 weeks -26.0% · Next-week setup negative 43.5% DCBO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Docebo (NASDAQ: DCBO) starts US$70M substantial issuer bid

Docebo Inc. (NASDAQ: DCBO) has launched a substantial issuer bid to repurchase up to 3,431,372 of its common shares at US$20.40 per share, totaling a maximum aggregate purchase price of US$70,000,000. The offer began on July 21, 2026, and is set to expire on …

DCBO main company
Sharemaestro market context Trend signal active 52 weeks -26.0% · Next-week setup negative 43.5% DCBO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Amdocs Ltd (DOX) Stock Price, Trades & News

This GuruFocus article provides a comprehensive overview of Amdocs Ltd (DOX), a provider of software and services to communications companies. It details the company's financial strength, growth, profitability, valuation metrics, and dividend information. The report also highlights recent news, analyst estimates, key statistics, and …

DOX main company
Sharemaestro market context New activity signal 52 weeks -32.6% DOX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Healthpeak & Brookfield Form Outpatient Medical Joint Venture

Healthpeak Properties, Inc. DOC and Brookfield Asset Management Ltd. BAM have formed a long-term strategic capital partnership through a joint venture involving a portfolio of outpatient medical buildings across the United States. DOC contributed 86 properties totaling about 5.6 million square feet, with the …

DOC main company
Sharemaestro market context Trend signal active 52 weeks +24.0% DOC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context